Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.
Am J Pathol
; 193(12): 2099-2110, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734590
2.
Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges.
Semin Cancer Biol
; 86(Pt 2): 477-490, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752398
3.
Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.
Physiol Rev
; 96(3): 805-29, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142452
4.
Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.
Lab Invest
; 103(12): 100259, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839638
5.
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Cancer
; 129(15): 2331-2340, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162404
6.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367007
7.
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
N Engl J Med
; 383(12): 1139-1148, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877599
8.
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
J Transl Med
; 21(1): 265, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072748
9.
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.
Br J Surg
; 110(7): 818-830, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131298
10.
Pathology of Immunotherapy-induced Responses in Cutaneous Melanoma: Current Evidences and Future Perspectives.
Adv Anat Pathol
; 30(3): 218-229, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36221225
11.
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.
Future Oncol
; 19(30): 2017-2027, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665297
12.
COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF.
Future Oncol
; 19(16): 1091-1098, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309702
13.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
J Eur Acad Dermatol Venereol
; 37(10): 1991-1998, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335879
14.
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
N Engl J Med
; 381(7): 626-636, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166680
15.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
Gastric Cancer
; 25(1): 197-206, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468869
16.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 643-654, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857412
17.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 655-664, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857414
18.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): 341-347, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355953
19.
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
N Engl J Med
; 378(19): 1789-1801, 2018 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658430
20.
Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review.
Int J Mol Sci
; 23(1)2021 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008570